NASDAQ | ETF
The index was established in 2023 by Range Fund Holdings and tracks the performance of a portfolio ofU. S. exchange-listed pharmaceutical or biotechnology stocks or American Depositary Receipts ("ADRs") with a market capitalization of more than 250 million.
The advisor attempts to invest all, or substantially all, of its assets in the component securities that make up the index.
Under normal circumstances, at least 80% of the fund"s total assets will be invested in the component securities of the index.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| AUTL | Autolus Therapeutics Ltd | Healthcare | Biotechnology | 2.49% |
| MGNX | MacroGenics Inc | Healthcare | Biotechnology | 2.32% |
| RVMD | Revolution Medicines Inc | Healthcare | Biotechnology | 2.18% |
| NK | NantKwest Inc | Healthcare | Biotechnology | 2.07% |
| FATE | Fate Therapeutics Inc | Healthcare | Biotechnology | 2.03% |
| YMAB | Y mAbs Therapeutics | Healthcare | Biotechnology | 1.90% |
| MRSN | Mersana Therapeutics Inc | Healthcare | Biotechnology | 1.89% |
| IMGN | ImmunoGen Inc | Healthcare | Biotechnology | 1.87% |
| SMMT | Summit Therapeutics PLC | Healthcare | Biotechnology | 1.83% |
| MRTX | Mirati Ther | Healthcare | Biotechnology | 1.77% |
| ACET | Adicet Bio Inc | Healthcare | Biotechnology | 1.74% |
| INBX | Inhibrx Inc | Healthcare | Biotechnology | 1.66% |
| ACLX | Arcellx Inc | Healthcare | Biotechnology | 1.64% |
| BPMC | Blueprint Medicines Corp | Healthcare | Biotechnology | 1.58% |
| IOVA | Iovance Biotherapeutics Inc | Healthcare | Biotechnology | 1.57% |
| NUVL | Nuvalent Inc | Healthcare | Biotechnology | 1.55% |
| ARVN | Arvinas Inc | Healthcare | Biotechnology | 1.55% |
| ZA8 | ZYMEWORKS DL-00001 | Healthcare | Biotechnology | 1.54% |
| SWTX | SpringWorks Therapeutics Inc | Healthcare | Biotechnology | 1.53% |
| KURA | Kura Oncology Inc | Healthcare | Biotechnology | 1.52% |